Rapport Therapeutics, Inc.
Total Trades
28
Buys
7
Sells
17
Largest Trade
N/A
Insiders
9
Institutional Funds
101
Inst. Value
$1M+
Activist Filings
16
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Ceesay Abraham | CEO | SELL | $100K–$500K | 11K | $26.11 | Jan 23, 2026 |
| Bredt David | Chief Scientific O… | SELL | $100K–$500K | 9K | $26.84 | Jan 16, 2026 |
| Bredt David | Chief Scientific O… | SELL | $100K–$500K | 7K | $30.05 | Jan 5, 2026 |
| Bredt David | Chief Scientific O… | GRANT | N/A | 18K | — | Jan 5, 2026 |
| Yeleswaram Krishnaswamy | Chief Development … | SELL | $50K–$100K | 3K | $30.05 | Jan 5, 2026 |
| Yeleswaram Krishnaswamy | Chief Development … | GRANT | N/A | 9K | — | Jan 5, 2026 |
| Ceesay Abraham | CEO | SELL | $100K–$500K | 11K | $29.64 | Dec 18, 2025 |
| Bredt David | Chief Scientific O… | SELL | $100K–$500K | 9K | $30.02 | Dec 16, 2025 |
| Gault Cheryl | COO | EXERCISE | $1K–$15K | 5K | $1.80 | Dec 1, 2025 |
| Gault Cheryl | COO | SELL | $100K–$500K | 5K | $30.10 | Dec 1, 2025 |
| Ceesay Abraham | CEO | SELL | $100K–$500K | 11K | $25.20 | Nov 18, 2025 |
| Bredt David | Chief Scientific O… | SELL | $100K–$500K | 9K | $25.19 | Nov 18, 2025 |
| Ceesay Abraham | CEO | SELL | $1M+ | 76K | $26.32 | Sep 19, 2025 |
| Bredt David | Chief Scientific O… | SELL | $100K–$500K | 9K | $24.19 | Sep 17, 2025 |
| Huber Reid M | Director | BUY | $100K–$500K | 20K | $24.48 | Sep 15, 2025 |
| PAUL STEVEN M | Director | BUY | $1M+ | 42K | $24.65 | Sep 15, 2025 |
| Young Wendy B. | Director | BUY | $50K–$100K | 4K | $22.60 | Sep 11, 2025 |
| Gault Cheryl | COO | EXERCISE | $1K–$15K | 5K | $1.80 | Sep 10, 2025 |
| Gault Cheryl | COO | SELL | $100K–$500K | 5K | $38.33 | Sep 10, 2025 |
| Bredt David | Chief Scientific O… | SELL | $100K–$500K | 9K | $14.00 | Jul 16, 2025 |
| Bredt David | Chief Scientific O… | SELL | $50K–$100K | 9K | $11.00 | Jun 18, 2025 |
| Bredt David | Chief Scientific O… | SELL | $50K–$100K | 9K | $9.56 | May 19, 2025 |
| Bredt David | Chief Scientific O… | SELL | $50K–$100K | 9K | $9.57 | Apr 16, 2025 |
| Bredt David | Chief Scientific O… | SELL | $50K–$100K | 9K | $10.85 | Mar 17, 2025 |
| Ignelzi Troy A. | CFO | BUY | $100K–$500K | 10K | $10.10 | Mar 13, 2025 |
| Young Wendy B. | Director | BUY | $50K–$100K | 6K | $10.21 | Mar 13, 2025 |
| HEALY JAMES | Director | BUY | $1M+ | 44K | $24.52 | Jul 4, 2024 |
| HEALY JAMES | Director | BUY | $1M+ | 559K | $17.00 | Jun 10, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 101 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| TRV GP V, LLC | 7.1M | $1M+ | SH |
| Capital International Investors | 3.4M | $1M+ | SH |
| Cormorant Asset Management, LP | 3.0M | $1M+ | SH |
| Sofinnova Investments, Inc. | 1.9M | $1M+ | SH |
| JOHNSON & JOHNSON | 1.8M | $1M+ | SH |
| GOLDMAN SACHS GROUP INC | 1.2M | $1M+ | SH |
| TRV GP VI, LLC | 969K | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 788K | $1M+ | SH |
| STATE STREET CORP | 715K | $1M+ | SH |
| Siren, L.L.C. | 708K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 674K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 601K | $1M+ | SH |
| Burkehill Global Management, LP | 250K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 244K | $1M+ | SH |
| PRUDENTIAL FINANCIAL INC | 215K | $1M+ | SH |
| Ensign Peak Advisors, Inc | 194K | $1M+ | SH |
| VANGUARD GROUP INC | 182K | $1M+ | SH |
| KENNEDY CAPITAL MANAGEMENT LLC | 179K | $1M+ | SH |
| Artia Global Partners LP | 139K | $1M+ | SH |
| UBS Group AG | 122K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Cormorant Asset Management, LP
SC 13G/A · Feb 17, 2026
6.3%
3.0M shares
SC 13G · Jan 21, 2026
5.0%
2.4M shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2025
6.7%
3.2M shares
SC 13G/A · Oct 22, 2025
4.9%
1.8M shares
Sofinnova Venture Partners XI, L.P. ("SVP XI")
SC 13D/A · Sep 18, 2025
4.0%
1.9M shares
SC 13G · Feb 13, 2025
19.5%
7.1M shares
(S) ARCH Venture Fund XII, L.P.
SC 13G · Nov 14, 2024
10.2%
3.7M shares
Cormorant Asset Management, LP
SC 13G/A · Nov 14, 2024
8.0%
2.9M shares
Capital International Investors 95-1411037
SC 13G · Nov 13, 2024
7.1%
2.6M shares
SC 13G/A · Nov 12, 2024
15.0%
5.5M shares
SC 13G · Oct 18, 2024
6.8%
2.5M shares
SC 13G · Jul 10, 2024
13.6%
5.0M shares
SC 13G/A · Jun 25, 2024
3.5%
1.3M shares
SC 13G · Jun 21, 2024
7.5%
2.7M shares
Cormorant Global Healthcare Master Fund, LP
SC 13G · Jun 20, 2024
3.5%
1.3M shares
Sofinnova Venture Partners XI, L.P. (“SVP XI”)
SC 13D · Jun 14, 2024
5.3%
1.9M shares